Table 1. Population, study design PEDro scale. |
Author |
Year |
Eligibility
criteria |
Random allocation |
Allocation concealment |
Baseline comparability |
Blind participants |
Blind assessor |
Blind therapist |
Follow-up |
Intention
to treat analysis |
Between
group comparisons |
Point measure
variability |
Total PEDro
score |
Abade et
al. |
2019 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Agostini
et al. |
2017 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Ahmed |
2015 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Al et al., |
2023 |
1 |
1 |
1 |
1 |
1 |
0 |
0 |
1 |
1 |
1 |
1 |
9 |
Ali et al. |
2019 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Aloui et
al. |
2019 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Fonseca et
al. |
2022 |
1 |
1 |
1 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
8 |
Martel et
al. |
2005 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Guimarães
et al. |
2023 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Kotzamanidis
et al. |
2005 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Taskin |
2016 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
0 |
5 |
Rubley et
al. |
2011 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Wong et al. |
2010 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Egesoy et
al. |
2021 |
1 |
1 |
1 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
8 |
Zhao et al. |
2023 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Taiar et
al. |
2019 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
0 |
5 |
Kurt et al. |
2023 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Seyhan |
2019 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Hetzler et
al. |
1997 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Chelly et
al. |
2009 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Garcia-Pinillos
et al. |
2014 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Latorre Román
et al. |
2018 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Khlifa et
al. |
2010 |
0 |
1 |
0 |
1 |
0 |
1 |
0 |
1 |
1 |
1 |
1 |
6 |
Hermassi
et al. |
2014 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Katushabe
and Kramer |
2020 |
1 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
7 |
Thapa et
al. |
2023 |
1 |
1 |
0 |
1 |
1 |
0 |
0 |
1 |
1 |
1 |
1 |
8 |
Wang and
Wang |
2023 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Nunes et
al. |
2021 |
1 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
7 |
Huang et
al. |
2023 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Lu |
2015 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Santos and
Janeira |
2012 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Asadi et
al. |
2017 |
1 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
7 |
Turkmen et
al. |
2022 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Barbalho
et al. |
2018 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Klusemann
et al. |
2012 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Saez de Villareal
et al. |
2023 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Alves et
al. |
2010 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Váczi et
al. |
2013 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Ramirez-Campillo
et al. |
2018 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Iacono et
al. |
2017 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Fowler et
al. |
1995 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Simpson et
al. |
2020 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Maciejczyk
et al. |
2021 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
Sawyer et
al. |
2021 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
|
|